Clinical Trial Detail

NCT ID NCT02120222
Title Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kari Kendra
Indications

melanoma

Therapies

Selinexor

Age Groups: adult

No variant requirements are available.